Lambert-eaton Myasthenic Syndrome
📧 Sign up to get email alerts when something new happens for Lambert-eaton Myasthenic Syndrome.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2019-05-21Clinical Trial Update: Controlled Trial of 3,4-Diaminopyridine (3-4DAP) in Lambert-Eaton Myasthenic Syndrome (LEMS) [Phase 2]
Phase 2 trial of 3,4-Diaminopyridine (3-4DAP) in Lambert-Eaton Myasthenic Syndrome (LEMS) was terminated; results posted.
-
CLINICAL_TRIALS trial_result · 2018-12-24Clinical Trial Update: Phase 3 Study to Evaluate Efficacy of Amifampridine Phosphate in Lambert-Eaton Myasthenic Syndrome (LEMS) [Phase 3]
Phase 3 trial evaluating amifampridine phosphate for Lambert-Eaton Myasthenic Syndrome has been completed with results posted in 2018.
-
CLINICAL_TRIALS trial_result · 2018-01-04Clinical Trial Update: A Phase 3 Study of Amifampridine Phosphate in Patients With Lambert Eaton Myasthenic Syndrome (LEMS) [Phase 3]
Phase 3 study of amifampridine phosphate in Lambert-Eaton myasthenic syndrome has been completed with results posted.
-
CLINICAL_TRIALS trial_result · 2017-07-11Clinical Trial Update: Effectiveness of 3,4-Diaminopyridine in Lambert-Eaton Myasthenic Syndrome [Phase 2]
A Phase 2 clinical trial evaluating the effectiveness of 3,4-Diaminopyridine in Lambert-Eaton Myasthenic Syndrome has completed and posted r…
-
CLINICAL_TRIALS trial_result · 2015-03-25Clinical Trial Update: Randomized Study of 3,4-Diaminopyridine for Lambert-Eaton Myasthenic Syndrome [NA]
A randomized study evaluating the use of 3,4-Diaminopyridine for Lambert-Eaton myasthenic syndrome has completed.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2013-07-18Clinical Trial Update: Treatment of Lambert-Eaton Myasthenic Syndrome (LEMS) With 3, 4 DAP
A clinical trial evaluating 3,4-DAP for Lambert-Eaton Myasthenic Syndrome is no longer available.